CRESUD S.A.-SPONS ADR(NASDAQ:CRESY) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CRESY. CRESY was compared to 91 industry peers in the Food Products industry. While CRESY is still in line with the averages on profitability rating, there are concerns on its financial health. CRESY has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

CRESY had positive earnings in 4 of the past 5 years.

Of the past 5 years CRESY 4 years had a positive operating cash flow.

1.2 Ratios

CRESY has a Return On Assets (1.22%) which is in line with its industry peers.

CRESY has a Return On Equity (6.03%) which is comparable to the rest of the industry.

CRESY has a Return On Invested Capital (5.55%) which is in line with its industry peers.

CRESY had an Average Return On Invested Capital over the past 3 years of 2.55%. This is significantly below the industry average of 9.02%.

The last Return On Invested Capital (5.55%) for CRESY is above the 3 year average (2.55%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	1.22%
ROE	6.03%
ROIC	5.55%

ROA(3y)4.46%

ROA(5y)1.27%

ROE(3y)25.84%

ROE(5y)3.92%

ROIC(3y)2.55%

ROIC(5y)1.98%

1.3 Margins

CRESY has a better Profit Margin (4.80%) than 66.28% of its industry peers.

CRESY's Operating Margin of 22.19% is amongst the best of the industry. CRESY outperforms 96.51% of its industry peers.

CRESY's Operating Margin has been stable in the last couple of years.

Looking at the Gross Margin, with a value of 37.69%, CRESY belongs to the top of the industry, outperforming 84.88% of the companies in the same industry.

CRESY's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	22.19%
PM (TTM)	4.8%
GM	37.69%

OM growth 3Y103.59%

OM growth 5Y-0.99%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y28.68%

GM growth 5Y-1.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRESY has less shares outstanding

CRESY has more shares outstanding than it did 5 years ago.

The debt/assets ratio for CRESY has been reduced compared to a year ago.

2.2 Solvency

CRESY has a Debt/Equity ratio of 0.77. This is a neutral value indicating CRESY is somewhat dependend on debt financing.

CRESY's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. CRESY is outperformed by 67.44% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.77
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

CRESY has a Current Ratio of 1.09. This is a normal value and indicates that CRESY is financially healthy and should not expect problems in meeting its short term obligations.

CRESY has a Current ratio of 1.09. This is in the lower half of the industry: CRESY underperforms 73.26% of its industry peers.

CRESY has a Quick Ratio of 1.09. This is a bad value and indicates that CRESY is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of CRESY (0.85) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.09
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CRESY have decreased strongly by -71.39% in the last year.

The Revenue has grown by 187.37% in the past year. This is a very strong growth!

CRESY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.80% yearly.

EPS 1Y (TTM)-71.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-168.66%

Revenue 1Y (TTM)187.37%

Revenue growth 3Y68.04%

Revenue growth 5Y71.8%

Sales Q2Q%193.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CRESY!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (1/22/2025, 11:46:53 AM)

12.59

-0.15 (-1.18%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)11-07 2024-11-07/amc

Earnings (Next)02-06 2025-02-06

Inst OwnersN/A

Inst Owner Change1.62%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap753.54M

Analysts85.71

Price TargetN/A

Short Float %1.61%

Short Ratio2.06

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP273.94%

Div Incr Years2

Div Non Decr Years2

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)N/A

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpSN/A

BVpSN/A

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.22%
ROE	6.03%
ROCE	7.02%
ROIC	5.55%
ROICexc	6.16%
ROICexgc	6.34%
OM	22.19%
PM (TTM)	4.8%
GM	37.69%
FCFM	N/A

ROA(3y)4.46%

ROA(5y)1.27%

ROE(3y)25.84%

ROE(5y)3.92%

ROIC(3y)2.55%

ROIC(5y)1.98%

ROICexc(3y)2.84%

ROICexc(5y)2.27%

ROICexgc(3y)2.9%

ROICexgc(5y)2.34%

ROCE(3y)3.23%

ROCE(5y)2.51%

ROICexcg growth 3Y84.33%

ROICexcg growth 5Y19.28%

ROICexc growth 3Y83.34%

ROICexc growth 5Y20.03%

OM growth 3Y103.59%

OM growth 5Y-0.99%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y28.68%

GM growth 5Y-1.65%

F-Score3

Asset Turnover0.25

Health

		Industry Rank	Sector Rank
Debt/Equity	0.77
Debt/FCF	N/A
Debt/EBITDA	2.59
Cap/Depr	598.93%
Cap/Sales	8.12%
Interest Coverage	1.52
Cash Conversion	19.3%
Profit Quality	N/A
Current Ratio	1.09
Quick Ratio	0.85
Altman-Z	N/A

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)595.85%

Cap/Depr(5y)423.1%

Cap/Sales(3y)8.46%

Cap/Sales(5y)6.95%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-71.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-168.66%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)187.37%

Revenue growth 3Y68.04%

Revenue growth 5Y71.8%

Sales Q2Q%193.39%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y295.01%

EBIT growth 3Y242.1%

EBIT growth 5Y70.1%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-626.01%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y223.15%

OCF growth 3YN/A

OCF growth 5Y5.31%

CRESUD S.A.-SPONS ADR (CRESY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens